Last reviewed · How we verify
Oncology Drugs — Competitive Intelligence Brief
phase 2
Small molecule
Live · refreshed every 30 min
Target snapshot
Oncology Drugs (Oncology Drugs) — Fondazione per la Medicina Personalizzata.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Oncology Drugs TARGET | Oncology Drugs | Fondazione per la Medicina Personalizzata | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Oncology Drugs CI watch — RSS
- Oncology Drugs CI watch — Atom
- Oncology Drugs CI watch — JSON
- Oncology Drugs alone — RSS
Cite this brief
Drug Landscape (2026). Oncology Drugs — Competitive Intelligence Brief. https://druglandscape.com/ci/oncology-drugs. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab